MedTrace Logo

Glycemic Relapse Prevention: Maintenance Dose Assessment

NCT00362193 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 165

Last updated 2010-02-15

No results posted yet for this study

Summary

This purpose of this study is to determine the optimal frequency of maintenance intervention needed to prevent glycemic relapse.

Conditions

Interventions

BEHAVIORAL

Telephonic diabetes care

Sponsors & Collaborators

  • Vanderbilt University

    collaborator OTHER

  • National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)

    lead NIH

Principal Investigators

  • Tom A Elasy, MD, MPH · Vanderbilt University

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-06-30
Completion
2007-02-28

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00362193 on ClinicalTrials.gov